Great Point Partners’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Great Point Partners’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-500,000	Closed	-$22.9M	–	46
2015 Q1	$22.9M	Sell	500,000 -498,066	-50%	-$14.9M	10.1%	2
2014 Q4	$24M	Buy	998,066 +204,202	+26%	+$4.6M	11.53%	2
2014 Q3	$20M	Buy	793,864 +135,880	+21%	+$3.37M	8.6%	1
2014 Q2	$17.2M	Buy	657,984 +164,233	+33%	+$4.22M	7.64%	2
2014 Q1	$12.7M	Sell	493,751 -317,362	-39%	-$8.6M	6.65%	2
2013 Q4	$16.4M	Sell	811,113 -9,793	-1%	-$231K	11.58%	1
2013 Q3	$21.4M	Buy	+820,906	New	+$20.6M	14.88%	1

Great Point Partners's HPTX Position: Q2 2015 in Review

Great Point Partners sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 500,000 shares — an estimated $22.9M sold.

Great Point Partners first reported a position in HPTX in Q3 2013 and held it in 7 quarters. The position peaked at $24M in Q4 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Great Point Partners reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Great Point Partners sold 500,000 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $22.9M.
Great Point Partners first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 7 quarters.
Great Point Partners's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $24M in Q4 2014.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Great Point Partners's 13F filing for Q2 2015, filed 14 Aug 2015.